Financials

News Discussions Technicals Seasonals

GTTX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to GENETETHER THERAPEUTICS INC. operating, investing, and financing activities

GTTX free cash flow for Q2 24 is -285.14 k CAD. For 2023, GTTX free cash flow was -627.41 k CAD and operating cash flow was -627.41 k CAD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CAD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—